ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed
Yeqing Zou
Matched on OpenAlex author ID A5112117779. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 6
- Pan-cancer analysis of Krüppel-like factor 3 and its carcinogenesis in pancreatic cancer. Last author DOI 10.3389/fimmu.2023.1167018↗
- E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. Last author DOI 10.1186/s12967-021-03007-w↗
- Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis Last author DOI 10.21203/rs.3.rs-86053/v1↗
- Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer … Co-author DOI 10.3892/or.2018.6760↗
- CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. Last author DOI 10.1007/s10620-017-4641-8↗
- Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Last author DOI 10.1016/j.bbrc.2016.11.120↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaowei Fu · 3 shared papers, 2017–2021 · strength 0.34
- Paper E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. DOI 10.1186/s12967-021-03007-w↗
- Paper Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of t… DOI 10.21203/rs.3.rs-86053/v1↗
- Paper CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. DOI 10.1007/s10620-017-4641-8↗
- Bo Huang · 3 shared papers, 2017–2020 · strength 0.28
- Paper Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of t… DOI 10.21203/rs.3.rs-86053/v1↗
- Paper Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. DOI 10.1016/j.bbrc.2016.11.120↗
- Paper CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. DOI 10.1007/s10620-017-4641-8↗
- Xueqiang Deng · 2 shared papers, 2020–2021 · strength 0.27
- Paper E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. DOI 10.1186/s12967-021-03007-w↗
- Paper Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of t… DOI 10.21203/rs.3.rs-86053/v1↗
- Jinfeng Zhu · 1 shared paper, 2023 · strength 0.22
- Zhiwei Zhong · 2 shared papers, 2017–2018 · strength 0.15
- Paper Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution,… DOI 10.3892/or.2018.6760↗
- Paper CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. DOI 10.1007/s10620-017-4641-8↗
- Lu Fang · 1 shared paper, 2021 · strength 0.14
- Weidong Xiao · 1 shared paper, 2020 · strength 0.13
- Xiangbao Yin · 1 shared paper, 2018 · strength 0.08
- Fan Zhou · 1 shared paper, 2018 · strength 0.08
- Linquan Wu · 1 shared paper, 2018 · strength 0.08
- Xiaozhong Wang · 1 shared paper, 2017 · strength 0.07
- Chuan Liu · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.